Evommune, Inc. (EVMN)
18.44
-3.46
(-15.80%)
USD |
NYSE |
Dec 08, 16:00
18.83
+0.39
(+2.11%)
Pre-Market: 20:00
Evommune Total Liabilities (Quarterly): 267.44M for June 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BillionToOne, Inc. | 143.48M |
| PTC Therapeutics, Inc. | 2.799B |
| Spyre Therapeutics, Inc. | 49.50M |
| Denali Therapeutics, Inc. | 129.42M |
| Quince Therapeutics, Inc. | 108.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.21M |
| Shareholders Equity (Quarterly) | -171.23M |
| Debt to Equity Ratio | -1.506 |
| Current Ratio | 9.403 |